The global pharmaceutical filtration market size was valued at USD 12.47 billion in 2023 and is expected to surpass around USD 18.37 billion by 2032 with a registered CAGR of around 4.4% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. pharmaceutical filtration market size was valued at USD 3.49 billion in 2023 and is expected to reach USD 5.19 billion by 2032, growing at a CAGR of 4.50% from 2023 to 2032.
North America dominates the pharmaceutical filtration market with a revenue share of 40% in 2022. The pharmaceutical industry in North America operates under strict regulatory standards set by agencies such as the U.S. Food and Drug Administration (FDA) and Health Canada. These regulatory bodies require pharmaceutical companies to adhere to high-quality standards in the production of drugs and therapeutic products. Filtration is a critical process in ensuring the purity and safety of pharmaceutical products, making advanced filtration technologies essential for compliance.
North America has a sizable biopharmaceutical sector that focuses on the production of biologics, including vaccines, antibodies, and other complex therapeutic proteins. The manufacturing processes for biopharmaceuticals often involve intricate filtration steps, driving the demand for specialized filtration technologies.
The growth of global pharmaceutical filtration market is being driven by growing investments and funding in research and development activities. In addition, the growing acceptance of advanced treatment therapies and methods. Moreover, the rising number of market players are heavily investing in manufacturing facilities globally. For example, AbbVie Inc. funded roughly $320 million in a new small molecule and biologic active pharmaceutical ingredients manufacturing facility in Singapore in October 2016. As a result, demand for innovative products is expected to increase as biopharmaceutical firms expand.
Another factor driving the growth of global pharmaceutical filtration market is the adoption of innovative technologies by market players. In addition, the market players are investing in research and development initiatives for launching new and latest products in the global market. For example, in 2016, AstraZeneca, a renowned healthcare business, funded over $5,890 million on research and development. Furthermore, the market for pharmaceutical filtration is growing due to the rising prevalence of chronic disorders like asthma and cancer. The global pharmaceutical filtration market is also propelled by the development of advanced drugs and medications over the forecast period.
| Report Coverage | Details |
| Market Size in 2023 | USD 12.47 Billion |
| Market Size by 2032 | USD 18.37 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 4.4% |
| Largest Market | Asia Pacific |
| Fastest Growing Market | Europe |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product, Technique, Application, Scale of Operation, Systems, Type, Geography |
| Companies Mentioned | Graver Technologies, LLC, Meissner Filtration Products, Inc., Merck & Co., Inc., Parker-Hannifin Corporation, Sartorius Stedim Biotech S.A., 3M Company, Amazon Filters Ltd., Danaher Corporation (Pall Corporation), Eaton Corporation Plc, General Electric Company (GE Healthcare) |
Themembrane filters segment dominated the pharmaceutical filtration market in 2022. This is owing to its versatility in applications such nanofiltration, ultrafiltration, cross-flow filtration, and microfiltration. As membrane filters are utilized in so many applications, the market share is predicted to grow significantly during the projection period.
The single use systems segment is fastest growing segment over the forecast period. These systems offer a number of benefits, including decreased contamination risk, reduced operation time, and ease of use. As a result, single use systems are projected to become more popular in upcoming years. They are also small in size, so they take up less room in factories.
The microfiltration segment dominated the pharmaceutical filtration market in 2022. Microfiltration is a technology for clarifying, separating, and purifying proteins that is widely utilized. The feed stream flows parallel to the membrane in tangential flow microfiltration, which prevents plant pollutants from clogging the membrane. The lateral flow microfiltration can thus be utilized to simplify difficult to filter results like crude plant extracts, which induce membrane fouling quickly when filtered with traditional dead-end procedures.
The ultrafiltration segment is expected to witness significant growth over the forecast period. Due to its various applications in protein purification, antibody processing, and vaccines, the ultrafiltration category is expected to increase at a profitable rate. The market players are laser focused on meeting the precise requirements of healthcare filtration processes. Merck Millipore, for example, introduced the Mobius FlexReady Solution in January 2013, which is a fully automated, ready-to-use solution that is perfect for contract manufacturing organizations with quickly changing demands.
The final product processing segment dominated the pharmaceutical filtration market in 2022. Due to its widespread use in active pharmaceutical component processing, vaccine processing, protein purification, virus clearance, and antibody processing, the final product processing segment is growing at a rapid pace over the forecast period.
The cell separation segment is projected to hit significant growth from 2023 to 2032. The synthesis of monoclonal antibodies, therapeutic proteins, and vaccines all need cell separation. For cell separation applications, depth filtration and microfiltration are widely utilized. These items are expected to be widely used in emerging and established nations. The leading healthcare firms, well developed healthcare infrastructure, and modern goods all support the growth of the segment.
The manufacturing scale segment dominated the pharmaceutical filtration market in 2022. Due to increased production of generic medications, biopharmaceuticals, and vaccines utilized for treatment of numerous disorders, the manufacturing scale of operation retained the biggest market share.
The research and development scale segment is predicted to hit notable growth over the forecast period. Due to increased funding and investment in research and development for new technology and product development, the research and development scale segment is expected to grow at a significant rate throughout the forecast period. For example, member organizations of the Pharmaceutical Research and Manufacturers of America spent roughly $58.8 billion on research and development in 2015.
Segments Covered in the Report
By Product
By Technique
By Application
By Scale of Operation
By Systems
By Type
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
